[Studies on cardiovascular drugs. 3. Absorption, distribution, excretion and metabolism of 8-((1,4-benzodioxane-2-yl) methyl)-3-oxo-1-thia-4,8-diazaspiro (4,5) decane maleate (Y-3506)].
D000284:Administration, Oral; D000818:Animals; D001646:Bile / Q000032:analysis; D001798:Blood Proteins / Q000378:metabolism; D002855:Chromatography, Thin Layer; D004147:Dioxins / Q000008:administration & dosage / Q000032:analysis / Q000378:metabolism* / Q000652:urine; D005243:Feces / Q000032:analysis; D005966:Glucuronidase; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D008298:Maleates / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D013141:Spiro Compounds / Q000378:metabolism; D013844:Thiazoles / Q000378:metabolism; D014316:Tritium
D001798:Blood Proteins; D004147:Dioxins; D008298:Maleates; D013141:Spiro Compounds; D013844:Thiazoles; D014316:Tritium; D005966:Glucuronidase